Exploring Bioactive Organic Compounds for Drug Discovery, 2nd Edition
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 16717
Special Issue Editor
Interests: small-molecule inhibitors; biosensors; chemical biology; G-quadruplex structures; molecular design and synthesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Many naturally occurring bioactive organic compounds, such as polyphenols, carotenoids, phytosterols, organic acids, omega-3 fatty acids, vitamins, nucleosides and nucleotides, and pentacyclic triterpenoids, have attracted attention because of their active biofunctions in the prevention of certain diseases. In recent years, both natural and synthetic or semi-synthetic bioactive organic compounds have been used in modern drug development as the compounds are a prolific source of important lead compounds and pharmacophores. These include anticancer and antimicrobial agents against drug-resistant bacteria, such as superbugs, antivirus agents, cardioprotective agents, and anti-inflammatory agents. To ensure pharmaceutical development to address modern health challenges, the molecular design, synthesis, and semi-synthesis of potentially bioactive compounds and systematic evaluation of their bioactivity, biotoxicity, and potential applications for pre-clinical trials are crucial. These multi-disciplinary investigations may integrate many areas of knowledge and expertise, including, but not limited to, molecular design and organic synthesis, chemical transformation and structure–activity relationship studies, bioactive compound library construction, high-throughput screening, drug-target identification, molecular simulation, in vitro and in vivo evaluations, and so on. Therefore, contributions from cross-disciplinary experts, such as synthetic chemists, medicinal chemists, phytochemists, biochemists, combinatorial chemists, analytical chemists, as well as other practitioners and engineers in related fields, are clearly highly important in supporting pharmaceutical development and advancement. This Special Issue aims to gather individual efforts to support new drug discoveries through the identification, synthesis, and evaluation of novel bioactive organic compounds that may provide positive impacts in various areas of human health.
Dr. Wing-Leung Wong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioactive compounds
- bioactivity evaluation
- drug discovery
- medicinal chemistry
- chemical biology
- natural products
- lead compounds and pharmacophores
- molecular design and organic synthesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Exploring Bioactive Organic Compounds for Drug Discovery in Molecules (15 articles)